- Home
- HLLY vs AUTL Comparison
HLLY vs AUTL Comparison
Compare HLLY & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HLLY | AUTL |
|---|---|---|
| Founded | 1903 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.2M | 433.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HLLY | AUTL |
|---|---|---|
| Price | $4.11 | $1.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $4.43 | ★ $8.33 |
| AVG Volume (30 Days) | 701.9K | ★ 2.6M |
| Earning Date | 03-10-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $598,132,000.00 | $51,128,000.00 |
| Revenue This Year | $1.75 | $672.42 |
| Revenue Next Year | $5.07 | $84.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $1.60 | $1.11 |
| 52 Week High | $4.43 | $2.70 |
Technical Indicators
Market Signals| Indicator | HLLY | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 47.70 | 42.41 |
| Support Level | $4.03 | $1.33 |
| Resistance Level | $4.27 | $1.56 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 40.82 | 16.04 |
Price Performance
Historical ComparisonAbout HLLY Holley Inc.
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.